Challenge: A mid-size biopharma with a cell therapy platform, considered using its technology
for vaccination. BIM was approached to guide in the R&D and business consideration of
choosing the best antigens.
Solution: After an initial analysis of the platform, BIM generated an overall work plan to
implement the R&D strategy. In parallel, our team assist the R&D team in conducting and
managing the R&D plan, until all POC milestones were achieved.
Made on
Tilda